Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Domínguez-Cruz

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Dermatitis : Contact, Atopic, Occupational, Drug|October 26, 2023
Real-World Clinical Experience of Dupilumab in the Treatment of Chronic Palmo-Plantar Eczema in Patients with Moderate-Severe Atopic Dermatitis: 52-Week Follow-UpFrancisco José Navarro-Triviño, Manuel Galán-Gutiérrez, José Carlos-Armario Hita, et al.
Life (Basel, Switzerland)|August 26, 2022
Atopic Dermatitis: Background, Objectives and Future Perspectives (Superresponders)Ricardo Ruiz-Villaverde, Javier Domínguez-Cruz, Francisco J Navarro-Triviño, et al.
Immunotherapy|May 17, 2023
Upadacitinib for moderate to severe atopic dermatitisFrancisco Navarro-Triviño, Sara Alcantara-Luna, Javier Domínguez-Cruz, et al.
International Journal of Environmental Research and Public Health|September 9, 2022
Validation of a Questionnaire to Assess the Perception of Women with Atopic Dermatitis in Family PlanningSara Alcantara-Luna, Ricardo Ruiz-Villaverde, Javier Domínguez-Cruz, et al.
Life (Basel, Switzerland)|September 28, 2021
Short-Term Effectiveness and Safety of Biologics and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review and Network Meta-AnalysisJosé-Juan Pereyra-Rodriguez, Sara Alcantara-Luna, Javier Domínguez-Cruz, et al.
Acta Dermato-Venereologica|March 6, 2025
Definition of the Concept of Super-responders in Atopic Dermatitis: A Spanish Delphi ConsensusJuan-Manuel Liñán-Barroso, Juan-Carlos Hernández-Rodríguez, Ricardo Ruiz-Villaverde, et al.
Life (Basel, Switzerland)|August 26, 2022
Long-Term Effectiveness and Safety of Biologic and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic ReviewAngela Ayen-Rodríguez, José-Juan Pereyra-Rodríguez, Francisco J Navarro-Triviño, et al.
Journal of the American Pharmacists Association : Japha|October 17, 2020
Direct-to-consumer, store-and-forward teledermatology with dermoscopy using the pharmacist as patient point-of-contactFrancisco Ildefonso Mendonça, Ana Lorente-Lavirgen, Javier Domínguez-Cruz, et al.
Pediatric Dermatology|May 3, 2022
Inter- and intra-observer variability in the selection of therapy for infantile hemangiomas among pediatric dermatologists in SpainMaría Colmenero, Javier Del Boz, José Bernabeu Wittel, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Dermatitis : Contact, Atopic, Occupational, Drug|October 26, 2023
Real-World Clinical Experience of Dupilumab in the Treatment of Chronic Palmo-Plantar Eczema in Patients with Moderate-Severe Atopic Dermatitis: 52-Week Follow-UpFrancisco José Navarro-Triviño, Manuel Galán-Gutiérrez, José Carlos-Armario Hita, et al.
Life (Basel, Switzerland)|August 26, 2022
Atopic Dermatitis: Background, Objectives and Future Perspectives (Superresponders)Ricardo Ruiz-Villaverde, Javier Domínguez-Cruz, Francisco J Navarro-Triviño, et al.
Immunotherapy|May 17, 2023
Upadacitinib for moderate to severe atopic dermatitisFrancisco Navarro-Triviño, Sara Alcantara-Luna, Javier Domínguez-Cruz, et al.
International Journal of Environmental Research and Public Health|September 9, 2022
Validation of a Questionnaire to Assess the Perception of Women with Atopic Dermatitis in Family PlanningSara Alcantara-Luna, Ricardo Ruiz-Villaverde, Javier Domínguez-Cruz, et al.
Life (Basel, Switzerland)|September 28, 2021
Short-Term Effectiveness and Safety of Biologics and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review and Network Meta-AnalysisJosé-Juan Pereyra-Rodriguez, Sara Alcantara-Luna, Javier Domínguez-Cruz, et al.
Acta Dermato-Venereologica|March 6, 2025
Definition of the Concept of Super-responders in Atopic Dermatitis: A Spanish Delphi ConsensusJuan-Manuel Liñán-Barroso, Juan-Carlos Hernández-Rodríguez, Ricardo Ruiz-Villaverde, et al.
Life (Basel, Switzerland)|August 26, 2022
Long-Term Effectiveness and Safety of Biologic and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic ReviewAngela Ayen-Rodríguez, José-Juan Pereyra-Rodríguez, Francisco J Navarro-Triviño, et al.
Journal of the American Pharmacists Association : Japha|October 17, 2020
Direct-to-consumer, store-and-forward teledermatology with dermoscopy using the pharmacist as patient point-of-contactFrancisco Ildefonso Mendonça, Ana Lorente-Lavirgen, Javier Domínguez-Cruz, et al.
Pediatric Dermatology|May 3, 2022
Inter- and intra-observer variability in the selection of therapy for infantile hemangiomas among pediatric dermatologists in SpainMaría Colmenero, Javier Del Boz, José Bernabeu Wittel, et al.
Pageof 1